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A B S T R A C T
TDP-43 pathology is a key feature of amyotrophic lateral sclerosis (ALS), but the mechanisms linking TDP-43 to
altered cellular function and neurodegeneration remain unclear. We have recently described a mouse model in
which human wild-type or mutant TDP-43 are expressed at low levels and where altered stress granule formation
is a robust phenotype of TDP-43M337V/− expressing cells. In the present study we use this model to investigate
the functional connectivity of human TDP-43 in primary motor neurons under resting conditions and in response
to oxidative stress. The interactome of human TDP-43WT or TDP-43M337V was compared by mass spectrometry,
and gene ontology enrichment analysis identified pathways dysregulated by the M337V mutation. We found that
under normal conditions the interactome of human TDP-43WT was enriched for proteins involved in tran-
scription, translation and poly(A)-RNA binding. In response to oxidative stress, TDP-43WT recruits proteins of the
endoplasmic reticulum and endosomal-extracellular transport pathways, interactions which are reduced in the
presence of the M337V mutation. Specifically, TDP-43M337V impaired protein-protein interactions involved in
stress granule formation including reduced binding to the translation initiation factors Poly(A)-binding protein
and Eif4a1 and the endoplasmic reticulum chaperone Grp78. The M337V mutation also affected interactions
involved in endosomal-extracellular transport and this this was associated with reduced extracellular vesicle
secretion in primary motor neurons from TDP-43M337V/− mice and in human iPSCs-derived motor neurons.
Taken together, our analysis highlights a TDP-43 interaction network in motor neurons and demonstrates that an
ALS associated mutation may alter the interactome to drive aberrant pathways involved in the pathogenesis of
ALS.
1. Introduction
The presence of ubiquitinated and phosphorylated aggregates of the
43 kDa transactive response DNA-binding protein (TDP-43) in the cy-
toplasm of neurons is one of the defining pathological hallmark of
amyotrophic lateral sclerosis (ALS) and approximately 50% of cases of
frontotemporal dementia (FTD) (Neumann et al., 2006). TDP-43 pa-
thology is also now recognised as a significant factor in at least 25% of
cases of late-onset cognitive decline designated as ‘limbic-predominant
age-related TDP-43 encephalopathy’ (LATE) and in chronic traumatic
encephalopathy (McKee et al., 2016; Nelson et al., 2019). The dis-
tribution of TDP-43 pathology within the central nervous system in ALS
correlates well with disease burden, although the mechanisms leading
to cell death remain unclear (Brettschneider et al., 2013; Lee et al.,
2011).
TDP-43 is a ubiquitously expressed heterogeneous nuclear ribonu-
cleoprotein (hnRNP) containing two highly conserved RNA-recognition
motifs (RRM) and a C-terminal glycine-rich domain (Kato et al., 2012;
Ou et al., 1995). Which of its diverse functions are key in ALS patho-
genesis remains unclear. The C-terminal region of TDP-43 is important
in its interaction with other proteins to regulate key cellular functions
such as alternative splicing and translation (Ayala et al., 2011; Buratti
and Baralle, 2008; Buratti et al., 2005; Ling et al., 2013), and in med-
iating liquid–liquid phase transitions, which are important for the
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biogenesis of membraneless organelles such as stress granules. How-
ever, this ‘low-complexity domain’ also renders TDP-43 prone to mis-
folding and aggregation (Conicella et al., 2016; Harrison and Shorter,
2017). Notably, ALS-associated mutations in TDP-43 are consistently
located in the C-terminus, suggesting that it mediates protein-protein
interactions critical to ALS pathogenesis (Sreedharan et al., 2008).
We recently described a mouse model with low level expression of
human TDP-43 from a single copy stably-integrated BAC genomic
construct containing human wild-type TDP-43 or C-terminal mutated
TDP-43 (M337V) with a C-terminal fluorescent protein tag (YPet)
(Gordon et al., 2019). Heterozygous TDP-43 M337V/− mice showed
motor deficits at 12 months and reduced survival at 2 years, compared
to non-transgenic mice. Importantly, these phenotypes were observed
in the absence of TDP-43 insoluble aggregates, suggesting it is relevant
model in which to study early pathological events upstream of protein
aggregation. In motor neurons differentiated from TDP-43M337V/− BAC-
transgenic mouse embryonic stem-cells (mESC) oxidative stress, an
important driver of neurodegeneration, led to a robust phenotype of
reduced stress granule formation (Gordon et al., 2019; Shaw et al.,
1995).
A number of proteomic studies have investigated TDP-43 inter-
actors, although these have generally not been conducted in primary
motor neurons with disease relevant phenotypes, and were lacking a
direct comparison between the wild-type protein and a C-terminal
mutant version of TDP-43, which may limit their relevance to ALS
pathogenesis (Blokhuis et al., 2016; Freibaum et al., 2010; Li et al.,
2016; Ling et al., 2010). The aim of the current study was therefore to
take advantage of the more physiological level of expression in this
model to investigate the functional connectivity of human TDP-43WT in
differentiated motor neurons at rest and in response to oxidative stress.
Hypothesising that TDP-43M337V mediates altered protein-protein in-
teractions that are linked to ALS pathophysiology, we then identified
specific pathways disrupted by the mutation and linked these to re-
producible cellular phenotypes in primary motor neurons.
2. Results
2.1. Low-level expression of human TDP-43M337V/− in primary motor
neuron cultures leads to reduced survival in response to oxidative stress
Mouse ES-cell derived motor neurons expressing YPet-tagged
human wild-type (TDP-43WT) or M337V mutant (TDP-43M337V) TDP-43
were lysed after 2 days of motor neuron specification, at which time-
point all cultures were also assessed for consistency. We observed no
obvious alteration in cell division or viability between genotypes.
Immunohistochemistry confirmed that 73% of total cells co-expressed
the neuronal marker Tuj1 and the early motor neuronal marker Islet1
(p = 0.196) (Fig. 1A and B), and over 70% of total cells co-expressed
Tuj1 and the mature motor neuronal marker ChAT (p = 0.557, sup-
plementary Fig.1). Immunoblotting showed human YPet-tagged TDP-
43WT or TDP-43M337V protein (72 kDa) at 0.17 and 0.14 times the level
of mouse endogenous Tdp-43 (43 kDa) (p = 0.99, respectively). En-
dogenous mouse Tdp-43 protein levels were equivalent between (BAC)-
transgenic and non-transgenic motor neuron lysates (p = 0.89) (Fig. 1C
and D).
Given our previous observation of altered stress granule dynamics in
TDP-43M337V mice, we also assessed motor neuron cultures under
conditions sufficient to induce stress granule formation by treating cells
with 0.5 mM NaAsO2 for 60 min. Importantly, the mESC-derived TDP-
43M337V/− motor neurons did not show mislocalization of human YPet-
tagged TDP-43 in basal or stress conditions, and thus any interactome
changes are not purely a consequence of a shift to cytoplasmic locali-
zation of human TDP-43M337V (Fig. 1E). NaAsO2 treatment was asso-
ciated with the expression of cleaved-caspase 3 in less than 20% of cells
in either genotype (p = 0.088, Fig. 1F). Significantly reduced survival
of TDP-43M337V/− compared to TDP-43WT/− motor neurons was
observed at 4 h after 60 min of NaAsO2 treatment (p = 0.0009,
Fig. 1G).
2.2. An ALS-associated C-terminal mutation alters the normal interactome
of human TDP-43
To determine the human TDP-43 interactome, wild-type or mutant
TDP-43 and their interactors were immunoprecipitated using GFP an-
tibody-coated beads from motor neuron lysates +/− 60 min of 0.5 mM
NaAsO2. The efficiency of the immunoprecipitation was confirmed by
immunoblotting and detection of the YPet-tagged TDP-43. GFP-im-
munoprecipitation from equal input amounts led to specific enrichment
of YPet-tagged TDP-43 at 72 kDa with complete depletion from the
supernatant, which contained the residual endogenous Tdp-43 at
43 kDa (Fig. 2A).
Across all GFP-immunoprecipitated samples, a total of 534 proteins
were co-immunoprecipitated and identified by mass spectrometry. As
expected, the YPet bait was detected equally in all samples. While some
proteins were equally abundant between genotypes, specific proteins
were differentially abundant in motor neurons expressing either TDP-
43WT or TDP-43M337V. Hierarchical clustering by genotype showed a
cluster of proteins with missing ion abundancies in TDP-43M337V sam-
ples (Fig. 2B). To take account of putative interactors that were specific
to either genotype, we determined the presence or absence of an in-
teractor using peptide spectral counts to avoid the imputation of
missing ion abundancies (Supplementary tables 1 and 2). This revealed
249 putative interactors that were present in the TDP-43WT inter-
actome, but absent in the TDP-43M337V interactome, which was also
reflected in a higher total spectral count number in all three replicate
samples for TDP-43WT (p = 0.036) (Fig. 2C). In contrast, 43 putative
interactors were specific to the TDP-43M337V interactome, with a higher
number of total spectral counts per sample compared to TDP-43WT
(p = 0.026). Similar findings were observed in the presence of oxida-
tive stress, where 203 proteins were specific for TDP-43WT and 26
proteins specific for TDP-43M337V, with a significantly reduced total
number of total spectral counts for specific interactors (both
p = 0.004). The number of putative interactors of TDP-43M3337V was
therefore reduced (Chi-square p = 0.03), suggesting that the mutation
is likely to have a significant effect on the normal function of TDP-43, in
addition to promoting aberrant protein-protein interactions which are
potentially toxic. Individual TDP-43WT or TDP-43M337V interactors of
particular interest in basal or stress conditions and their abundance by
spectral counts are given in Fig. 2D. Our data shows considerable
overlap with previous TDP-43 wild-type interactome studies (Supple-
mentary Fig. 2) (Freibaum et al., 2010; Ling et al., 2010). 62% of nu-
clear and 78% of cytoplasmic interactors were in common with the
study of Freibaum et al. Compared to the most stringent interactome
study that used absolute quantification with affinity purification mass
spectrometry (AP-MS), TDP-43WT in our study had 50% of nuclear in-
teractors and 36% of other interactors in common (Ling et al., 2010).
For the TDP-43M337V interactome no previous mass spectrometry is
available for direct comparison, but in line with our results, overlap
with the wild-type interactome reported in previous studies was greatly
reduced (23%, 27% and 28% respectively).
2.3. Mutant TDP-43 induces a shift towards acquired interactions in
pathways linked to ALS pathogenesis
Gene ontology (GO) enrichment analyses of the putative interactors
specific for either TDP-43WT or TDP-43M337V demonstrated differences
in their functional role. Proteins bound to TDP-43WT were enriched for
terms including ‘transcription’ (odds ratio, OR 5.5, p = 0.03), ‘trans-
lation’ (OR 3.2, p = 0.02), ‘ribosome formation’ (OR 1.8, p = 0.003),
and ‘Poly(A)-RNA binding’ (OR 1.4, p= 0.004) (Fig. 3A). In response to
NaAsO2 stress treatment the TDP-43WT interactome gained 92 new in-
teractors (Supplementary Fig. 3A), with a shift towards proteins
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enriched for terms including ‘endoplasmic reticulum’ (OR 4.5,
p = 0.02), ‘calcium binding’ (OR 3.5, p = 0.001) and ‘endosomal
transport and extracellular exosome’ (OR6.1, p = 0.03 and OR 1.2,
p = 0.04) (Fig. 3B). Network analysis confirmed the connectivity of
proteins involved in transcription and ribosome formation in basal
conditions in TDP-43WT samples, and again demonstrated a clear shift
towards protein-protein interactions involved in endosomal-exosomal
transport in response to oxidative stress (Fig. 3C and supplementary
tables 3 and 4). This suggests potentially distinct condition-dependent
functions of TDP-43WT in motor neurons, with a predominant role in
DNA/RNA metabolism in basal conditions and a shift in function to-
wards intracellular trafficking in response to stress.
In contrast, the TDP-43M337V interactome in basal conditions was
enriched for different GO terms including ‘protein folding’ (OR 13.3,
p = 0.006) and ‘filamin binding’ (OR 13.3, p = 0.005) (Fig. 3A). In-
terestingly, complexes of the dihydropyrimidinase-related proteins,
DPYSL1 (Crmp1) and DPYSL3, were highly abundant in the TDP-
43M337V interactome (Supplementary table 1 and 2). These proteins are
known to be modified in neurodegeneration and are involved in several
ALS-associated pathways including axonal transport, glutamate ex-
citotoxicity and oxidative stress (Blasco et al., 2013). Importantly, in
response to stress the TDP-43M337V interactome revealed significant GO
terms distinct from those seen with TDP-43WT, with high odds ratios for
protein ubiquitination (OR 28, p = 0.001), protein homo-oligomer-
ization (OR 50, p = 0.0001) and endosomal to lysosomal transport (OR
8, p = 0.02) (Fig. 3B).
In comparison, GO enrichment of the shared background proteome
of both genotypes showed terms for common cellular components such
as the cytosolic skeleton, myelin sheath and ribosomal subunits
(Supplementary Fig. 3B). Together this indicates that the M337V mu-
tation disturbs the normal TDP-43 interactome in a way that is likely to
affect its downstream function, with a shift towards pathways that have
been previously established to have a role in ALS pathogenesis.
2.4. Protein interactions underlying translation and stress response
pathways are disrupted by the M337V mutation
Our mass spectrometry data analysis identified TDP-43WT binding
proteins important for translation and the cellular response to stress.
Given the important role of Pabpc in both protein translation, but also
as a component of stress granules, we next specifically focused on in-
vestigating the interaction between Pabpc and TDP-43.
Fig. 1. Low-level expression of human TDP-43M337V/− in (BAC)-transgenic MNs leads to reduced survival in response to oxidative stress.
A Immunostaining for Islet1 and Tuj1 in TDP-43WT/− and TDP-43M337V/− cell lines (scale bar 50 μm). B Quantification of Tuj1 and Islet1 positive cells between
genotypes (p = 0.196) C Immunoblotting with anti-TDP-43 full-length antibody shows absent human YPet-tagged TDP-43 at 72 kDa in non-transgenic (NTG) cell
lysates. D Quantification of immunoblots shows mouse Tdp-43 levels at 43 kDa (p = 0.89, one-way ANOVA) and low expression of human TDP-YPet levels
(p = 0.99). E TDP-YPet was retained in the nucleus of ChAT positive MNs +/− 0.5 mM NaAsO2 treatment (scale bar 10 μm). F Quantification of cleaved-caspase 3
positive cells after 1 h NaAsO2 treatment between genotypes (p = 0.088). G Reduced survival in TDP-43M337V/− MNs after 1 h NaAsO2 treatment (⁎⁎⁎p = 0.001).
N = 62–124 MNs from three independent differentiations; unpaired t-test; TDP-43WT/− (blue), TDP-43M337V/− (red), symbols (+,ο,∇) represent number of positive
stained cells per field and differentiation. Data are represented as mean ± SD. Abbreviations: DAPI, 40,6-Diamidino-2-Phenylindole; MNs, motor neurons. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
E. Feneberg, et al. Neurobiology of Disease 144 (2020) 105050
3
Co-immunoprecipitation experiments were performed from differ-
entiated mouse motor neuron lysates, which showed that the normal
TDP-43WT and Pabpc interaction, is reduced in TDP-43M337V motor
neurons under basal (p = 0.049) and NaAsO2 stress (p = 0.047) con-
ditions (Fig. 4A), while protein input levels were similar in both
conditions (p= 0.93) and genotypes (basal p= 0.97, stress p= 0.9). In
line with the existing literature this interaction was not directly affected
by the M337V mutation when overexpressed in HEK293T cells (Sup-
plementary Fig. 4A). However, the interaction was abrogated by RNase
treatment (p = 0.045) (Supplementary Fig. 4B). This therefore suggests
Fig. 2. The TDP-43 interactome is altered by the C-terminal TDP-43 mutation.
A Immunoblotting with anti-TDP-43 full-length antibody shows enrichment of human YPet-tagged TDP-43WT and TDP-43M337V at 72kDA after IP. B Hierarchical
cluster of protein abundance analysed by LC-MS/MS from Co-IPs across TDP-43WT (blue), TDP-43WT + NaAsO2 (dark blue), TDP-43M337V (red) and TDP-
43M337V + NaAsO2 (dark red) samples (n = 3 independent differentiations per sample). C Venn diagrams show the total number of proteins identified by spectral
counting in the TDP-43WT or TDP-43M337V interactome (top) and the NaAsO2 treated interactomes (bottom) with a reduction of proteins identified for TDP-43M337V.
The total spectral counts of the specific TDP-43WT or TDP-43M337V (⁎p = 0.036 and p = 0.026), and TDP-43WT + NaAsO2 or TDP-43M337V + NaAsO2 interactors (⁎⁎,
both p = 0.004) are higher; unpaired t-test. D Examples of proteins bound to TDP-43WT, TDP-43M337V or both in basal and stress conditions. Data are represented as
mean ± SD. Abbreviations: IP, Immunoprecipitation; MN, motor neuron. (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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that the changes in the TDP-43M337V interactome in our model may
involve motor neuron specific RNA dependent protein interactions,
including translational proteins such as Pabpc.
To extend these observations to other interactors affected by the
M337V mutation and involved in RNA processing, we investigated
Eif4a1, a subunit of the Eif4f translation initiation factor complex acting
upstream of the binding of Pabpc to RNA, and independently associated
with stress granule assembly (Kimball et al., 2003). By mass spectro-
metry we found Eif4a1 to be highly abundant in the TDP-43WT inter-
actome under basal conditions, but deficient in the TDP-43M337V in-
teractome (Fig. 2D). Co-immunoprecipitation of Eif4a1 and
immunoblotting confirmed the TDP-43WT and Eif4a1 interaction and a
reduction in interaction of Eif4a1 with TDP-43M337V (p = 0.041), while
total protein levels of Eif4a1 were similar between genotypes
(p = 0.487) (Fig. 4B).
Next, we looked at differences in TDP-43 interactions in direct re-
sponse to oxidative stress. Grp78 was shown to be a specific TDP-43WT
interactor with significantly increased ion abundances compared to
TDP-43M337V by mass spectrometry (p = 0.015) (Fig. 2D). It has an
important role in the correct folding and degradation of proteins and
regulates the unfolded protein response of the endoplasmic reticulum.
By co-immunoprecipitation we confirmed the TDP-43WT and Grp78
Fig. 3. The physiological function of TDP-43 demonstrated by human TDP-43WT interactors is disturbed by the M337V mutation and reveals ALS associated
pathways.
A-B Gene Ontology enrichment analysis for significant terms (p < 0.05, Fisher's exact test) by number of annotated interactors from the human TDP-43WT
interactome (blue) and TDP-43M337V (red) interactome (a) and in response to 60 min of 0.5 mM NaAsO2 treatment (b). C Protein-protein interaction network analysis
of TDP-43WT shows a cluster of interactions for proteins involved in transcription and splicing, ribosome formation and translation, (left); in response to stress those
clusters resolve (right), while interactions of the endosomal-exosomal pathway form. Pabpc, Eif4a1, Grp78 (synonym name Hspa5) and Tmed9, Rab7 are indicated
by red circles. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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interaction and a reduction in interaction of Grp78 with TDP-43M337V
after stress treatment (p = 0.043), while input levels of Grp78 were
similar between motor neuron lysates (p = 0.84) (Fig. 4C).
Stress granules are RNA-containing cytoplasmic foci formed
through liquid-liquid phase separation and are enriched for low com-
plexity domain-containing proteins, including TDP-43 and Pabpc
(Colombrita et al., 2009). We previously showed in primary embryonic
spinal neurons derived from TDP-43M33V/− mice that fewer Pabpc-po-
sitive stress granules were detected in response to 60 min of NaAsO2
treatment (Gordon et al., 2019). We confirmed that the mESC-derived
motor neurons used in this study reproduced this phenotype and that
stress granules in TDP-43 M337V/− motor neurons are smaller (Fig. 5).
This study of an ALS associated mutation in a cellular model therefore
suggests that alterations in the interactome of mutant TDP-43 are as-
sociated with altered stress granule response to oxidative stress. How-
ever, further work would be required to demonstrate a precise me-
chanistic link for differentially interacting proteins in stress granule
assembly.
2.5. M337V mutant TDP-43 disrupts endosomal-exosomal protein
pathways and impairs extracellular vesicle secretion
A number of previous studies have provided evidence of a link be-
tween endovesicular recycling pathways and ALS, either in the context
of autophagy, exosome secretion or axonal vesicular transport (Aoki
et al., 2017; Sleigh et al., 2020). Knock-down of TDP-43 also has a
Fig. 4. Protein interactions of human wild-type TDP-43 are disrupted by the C-terminal mutation.
a Co-IP of human YPet-tagged TDP-43 from mouse MN lysates. Immunoreactivity of mouse Pabpc at 75 kDa is reduced in TDP-43M337V +/− NaAsO2 IPs.
Immunoreactivity of TDP-YPet at 72 kDa confirms efficiency of the IP. Co-IPs showing Pabpc levels relative to normalized TDP-YPet in TDP-43M337V compared to
TDP-43WT in basal (⁎p= 0.049, unpaired t-test) (n = 3 differentiations) and after 60 min of 0.5 mM NaAsO2 treatment (n= 4 differentiations) (⁎p=0.047, unpaired
t-test). Pabpc levels are unaltered in MN input lysates +/-NaAsO2 (p = 0.927) and between genotypes (basal, p = 0.97; stress p = 0.9; two-way ANOVA). B Eif4a1
co-immunoprecipitates with TDP-43WT at 48 kDa in basal conditions. C Grp78 co-immunoprecipitation with TDP-43WT or TDP-43M337V in stress conditions. Grp78
levels are unaltered in MN input lysates between genotypes (p = 0.84, one-way ANOVA). B and C N = 3 independent differentiations. Data are represented as
mean ± SD. Abbreviations: Co-immunoprecipitations, Co-IP; MNs, motor neurons; IP, Immunoprecipitation, L, Ladder.
Fig. 5. Poly(A)-binding protein positive stress granule formation is dysregulated in TDP-43M337V/− ESC-derived motor neurons.
Immunostaining of Tuj1- and Pabpc-positive neurons treated for 60 min with 0.5 mM NaAsO2 for automated macro analysis to assess stress granules per cell. Scale
bar 10 μm. Quantification shows the number and average area (nm2) of stress granules per neuron are reduced in human TDP-43M337V/− neurons (both ⁎p = 0.019
and p = 0.013, unpaired t-test). N = 23–25 cells from three independent differentiations. Data are represented as mean ± SD.
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direct impact on endosomal trafficking (Schwenk et al., 2016). In our
detailed proteomic data, the TDP-43WT interactome is also highly en-
riched in proteins of the endosomal-exosomal pathway, including pro-
teins that target endosomal trafficking towards extracellular secretion.
In contrast, the TDP-43M337V interactome showed a shift towards pro-
tein interactors regulating endosomal-lysosomal degradation through
interaction with VPS41 (Supplementary table 2). Tmed9 and Rab7-
GTPase are putative interactors of TDP-43WT (in the context of NaAsO2
treatment) involved in the extracellular-exosome pathway. There is
evidence of weak Tmed9 binding to TDP-43WT by co-im-
munoprecipitation, with reduced immunoreactivity with TDP-43M337V,
but this decrease did not reach statistical significance (p = 0.12)
(Supplementary Fig. 5) and we could not confirm an interaction of
rab7-GTPase to TDP-43WT or TDP-43M337V by immunoblotting. How-
ever, given that Tmed9 and rab7-GTPase were low abundancy proteins
in the TDP-43WT + NaAsO2 interactome among 60 other significant
proteins involved in extracellular-exosome secretion, we therefore
asked if we can observe a direct phenotypic alteration in extracellular
vesicle secretion.
Culture medium was collected from equal quantities of plated
mouse motor neurons (p = 0.372, supplementary table 5), and the
number of extracellular vesicles were quantified by nanoparticle
tracking analysis (NTA) following ultrafiltration liquid chromato-
graphy. Under basal conditions, no difference in the total number of
extracellular vesicles recovered per ml of conditioned media was de-
tectable between genotypes (p = 0.56, Fig. 6a) and between (BAC)-
transgenic and non-transgenic mouse motor neurons (p= 0.71, Fig. 6f).
However, after 60 min of NaAsO2 stress treatment, a reduction in the
number of vesicles was seen in conditioned media from TDP-43M337V/−
cells, suggesting that the M337V mutation affects extracellular vesicle
secretion (p = 0.048). By NTA of concentrated extracellular vesicle
peak fractions we demonstrated that the size distribution in both gen-
otypes is characteristic of a mixed population of vesicles. Vesicles in the
size range from 40 to 100 nm are typically exosomes arising from en-
dosomal pathways and the EV peak at 85 nm is decreased for TDP-
43M337V/− MNs + NaAsO2 and the area under the curve for exosomes
(40–100 nm) and a mixed population of EVs (100–200 nm) (⁎p = 0.02
and ⁎⁎p = 0.004) (Fig. 6b) (Thery et al., 2006).
To verify that this finding was not limited to a model in which
human TDP-43 is expressed in the mouse context, we extended our
observations to human iPSC-derived motor neurons. In response to
NaAsO2 treatment a reduction in the total number of vesicles of
40–100 nm and 100–200 nm, representing exosomes and extracellular
vesicles, was observed in conditioned media from iPSC-derived MNs
from an ALS patient with the M337V mutation compared to controls
(p= 0.049, Fig. 6c-d). Extracellular vesicle fractions were confirmed by
immunoblotting with antibodies against Alix, Tsg101 and Flotillin-1, as
well as negative markers of the endoplasmic reticulum, mitochondria
and nucleus. The presence, size and morphology of vesicles were fur-
ther confirmed by transmission electron microscopy (Fig. 6e). These
results suggest that extracellular vesicle formation or release is im-
paired in human and mouse motor neurons by TDP-43M337V through
disruption of elements of the wild-type TDP-43 interactome in response
to cellular stress.
3. Discussion
A major challenge in neurodegenerative disease is to link cellular
phenotypes in model systems directly with the molecular mechanisms
driving loss of homeostasis and cell failure. Despite a large number of in
vitro and in vivo studies based on TDP-43 models, the mechanisms
whereby mutations in TARDBP lead to ALS remain uncertain.
Most interactomes are derived from wild-type TDP-43 expressed in
non-motor neuron models that do not show an ALS-related phenotype
(Blokhuis et al., 2016; Freibaum et al., 2010; Ling et al., 2010). The key
question of how ALS-determining mutations are tolerated for long
periods before triggering motor neuron degeneration requires inter-
actome models in which TDP-43 overexpression itself is not toxic and
which are relevant for ALS pathology. In this study we have taken
advantage of a transgenic mouse model of ALS, in which the wild-type
and the mutant TDP-43 genomic construct is site-specifically integrated
as a single copy, to drive human TDP-43 from its native promoter
throughout the differentiation process of motor neurons (Gordon et al.,
2019). Affinity purification of epitope-tagged TDP-43 allowed us to link
mutant-specific alterations in the TDP-43 interactome with the phe-
notypic alterations we observed in mutant TDP-43 motor neurons.
3.1. M337V mutation disturbs the normal TDP-43 interactome
Our data demonstrate that the highly functional TDP-43 inter-
actome in motor neurons is disturbed by the presence of the M337V
mutation. First, we confirmed previous findings that, under basal con-
ditions, human TDP-43WT interacts with proteins involved in tran-
scription, splicing and translation (Freibaum et al., 2010). We then
showed that TDP-43M337V binding to previously reported interactors,
such as Hnrnpa2b1, was maintained in our model (Buratti et al., 2005;
D'Ambrogio et al., 2009). However, the absence of splicing factors (eg;
Srsf7, Srsf4, Sf3b3) and the confirmed interruption of the interaction
with Pabpc and Eif4a1 suggests potential contributions from dysregu-
lated splicing, mRNA export and translation to ALS pathogenesis
(Colombrita et al., 2012; Muller-McNicoll et al., 2016; Tollervey et al.,
2011). Importantly, Pabpc is known to assemble in polysomes with
other proteins implicated in translational dysregulation in ALS in-
cluding Ataxin-2 and Matrin 3 (Boehringer et al., 2017; Nonhoff et al.,
2007). Binding of TDP-43WT to Pabpc may therefore be an important
mediator of normal RNA processing in the cytoplasm of motor neurons
(Ayala et al., 2011; Craig et al., 1998; He et al., 2014; Zhang et al.,
2014). As we and others have shown, the M337V mutation is not in
itself sufficient to interrupt the binding of Pabpc to TDP-43 (Freibaum
et al., 2010). We suggest that a dysregulation in RNA metabolism may
indirectly affect its interaction.
3.2. TDP-43M337V alters stress response pathways
Oxidative stress increases with aging and is an important con-
tributing factor to the pathology of neurodegenerative conditions and a
potent trigger to stress granule formation (Guil et al., 2006). We found
that in response to oxidative stress, TDP-43WT interactions shift from
networks regulating basal transcription and translation towards pro-
teins involved in the endoplasmic reticulum-unfolded protein response,
endosomal transport and extracellular exosome. This is in keeping with
the protective response of general downregulation of translation in the
cell, in which the capacity of TDP-43 to maintain interactions with
stress response proteins and the formation of stress granules plays an
important role (Kedersha and Anderson, 2002). The TDP-43M337V/−
mutation in our model is associated with altered stress granule forma-
tion, a phenotype that has also been described in other ALS disease
models, and may be mediated by the dynamic interaction of a wide
repertoire of cytoplasmic RNA-binding proteins (Markmiller et al.,
2018). Based on our study, we suggest that reduced binding between
mutant TDP-43M337V and Pabpc and Eif4a1, which are important for the
initial assembly of stress granules, may be linked to impaired stress
granule formation observed in TDP-43M337V/− mutant motor neurons,
although demonstration of a direct effect of these interactors with stress
granule formation is beyond the scope of this study. In response to
stress, we found Grp78 bound preferentially to TDP-43WT. Endoplasmic
reticulum chaperones have been previously identified in association
with ALS-related proteins, which suggests an important role of cha-
perones in maintaining protein homeostasis in motor neurons, possibly
even within the cytoplasm (Atkin et al., 2006; Kikuchi et al., 2006;
Walker et al., 2013). This is in line with the role of Grp78 in the as-
sembly and disassembly of stress granules and conservation of the
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integrity of stress granule components including Eif4a1 (Buchan, 2014;
Matsumoto et al., 2011; Walker et al., 2013). In contrast, our proteomic
data identified proteins in the TDP-43M337V + NaAsO2 interactome that
are known to inhibit the formation of stress granules such as the cha-
peronin-containing T complex (CCT complex) (Jain et al., 2016; Leitner
et al., 2012). In TDP-43 overexpression models, stress granule forma-
tion has often been reported as increased and associated with toxic
aggregate formation, giving rise to the theory that stress granules seed
TDP-43 aggregation (Chew et al., 2019; Li et al., 2013; Liu-Yesucevitz
et al., 2010). However, a recent model in which TDP-43 proteinopathy
is driven by optogenetic control has demonstrated that pathological
aggregation of TDP-43 may occur independently of stress granule for-
mation, albeit in the context of overexpression (Mann et al., 2019).
Specific interactors gained by TDP-43M337V in stress conditions such as
Kelch-like proteins Klh15 and Kbtb4 and the loss of Grp78 interaction
suggest involvement of the ubiquitin-proteasome pathway and activa-
tion of the unfolded protein response, which have been independently
linked to ALS pathogenesis (Wang et al., 2010).
Consistent with the observation that knock-down of TDP-43 has a
direct impact on endosomal trafficking (Schwenk et al., 2016), we
Fig. 6. In response to stress extracellular vesicle secretion is decreased in TDP-43M337V/− mouse and human ALS iPSC-derived MNs.
A Total number of EVs per ml condition media from TDP-43M337V/− and TDP-43WT/− mouse MNs in basal conditions, and in response to NaAsO2 (⁎p = 0.048, n = 4
differentiations). B Size distribution of EVs given as total number per ml of conditioned media. C Total numbers of EVs from hiPSC-derived MNs from three healthy
control lines and three clonal lines of an ALS patient with the M337V mutation. D The EV peak at 93 nm is decreased in ALS MNs and the area under the curve for
exosomes (40–100 nm) and a mixed population of EVs (100–200 nm) (both ⁎p = 0.02 and p = 0.04). E Transmission electron microscopy of EV extracts (scale bar
100 nm). EV extracts are immunoreactive for Alix at 96 kDa, Tsg101 at 48 kDa and Flotillin-1 at 48kDA. The immunoblot was negative for markers of the nucleus
(Lamin B at 66 kDa), the endoplasmic reticulum (Erp44 at 38 kDa) and mitochondria (Tomm20 16 kDa). F The total number of EVs recovered from basal conditioned
media is similar between TDP-43WT/− and TDP-43M337V/− (BAC)-transgenic MNs and non-transgenic MNs (p = 0.71, one-way ANOVA). Unpaired t-test; data are
represented as mean ± SD. Abbreviations: EV, extracellular vesicle, hiPSC, human induced pluripotent stem-cells, MN, motor neuron.
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demonstrated interaction of TDP-43WT with proteins of the endosomal-
extracellular vesicle secretion pathways. This included proteins such as
Tmed9 which target vesicle transport to the plasma membrane for se-
cretion. TDP-43M337V/− motor neurons, lack this interaction and
showed a decrease in extracellular vesicle secretion compared to TDP-
43WT/− motor neurons in response to stress. Importantly this was in-
dependently confirmed in human iPSC-derived motor neurons from a
patient with the same mutation. This suggests that recognition of TDP-
43M337V by the endosomal sorting complexes required for transport and
secretion may be impaired in ALS neurons (Colombo et al., 2013).
Whether this is due to a direct interaction such as with the Ras-related
proteins (Aoki et al., 2017) or through an indirect mechanism, such as
activation of the proteasome-ubiquitin pathway by TDP-43M337V
(Iguchi et al., 2016), remains to be confirmed. Ultimately, reduced
cytoplasmic trafficking of TDP-43 is likely to be a factor in the forma-
tion of cytoplasmic TDP-43 aggregates observed in 97% of ALS cases,
and therefore could reflect a common therapeutic target upstream of
protein aggregation (Chen-Plotkin et al., 2010; Winton et al., 2008).
In conclusion, in this study we observed that a single C-terminal
mutation has multiple functional consequences, resulting in a patho-
logical stress response which, under chronic conditions, might ulti-
mately result in decreased survival of motor neurons. We focussed on
the effect of mutant TDP-43 on protein-protein interactions, however
we cannot rule out a contribution to pathology from differential TDP-43
binding to nucleic acids (Lim et al., 2016). Whether a loss of function of
TDP-43 through impaired RNA-binding capacity, translation and spli-
cing dysfunction or a toxic gain of function is a primary driver of ALS
pathology is still a matter of debate (Lee et al., 2011; Ling et al., 2013).
However, the results of this study support the hypothesis that multiple
TDP-43 mediated pathways may be dysregulated in response to oxi-
dative stress. This is also consistent with the concept of an age-depen-
dent multiple hit model of neurodegeneration, in which loss of toler-
ance to inherent genetic mutations leads to the ultimate loss of cellular
homeostasis in ALS.
4. Methods and materials
4.1. Motor neuron culture from mouse embryonic stem-cells
Mouse ESC-derived motor neurons were generated from the same
ESC lines (IDG26.10–3) originally used in the creation of a bacterial
artificial chromosome (BAC)-transgenic mouse model
(RRID:IMSR_JAX:029266) carrying human YPet-tagged TDP-43WT/− or
TDP-43M337V/− as previously described (Gordon et al., 2019; Wiese
et al., 2010). We have recently described this model, in which human
TDP-43 is expressed from a genomic insert integrated into the Rosa26
(Gt(ROSA26)Sor) locus of the mouse genome as a single stable copy,
leading to expression levels below that of endogenous Tdp-43. Briefly,
mESC were expanded on irradiated CF1 mouse embryonic fibroblasts
(Gibco, RRID:CVCL_RB05) in Knockout DMEM (Invitrogen) containing
15% ESC-screened foetal bovine serum (ThermoFisher), 2 mM L-gluta-
mine (Invitrogen), 0.01% MEM non-essential amino acids (Invitrogen),
1 ng/ml leukaemia inhibitory factor (Millipore), 0.01% EmbryoMax
ESC qualified nucleosides (Millipore) and 0.1 mM 2-mercaptoethanol
(Invitrogen). After 2 days embryoid bodies were separated from the
feeder layer by treatment with 0.25% trypsin-EDTA (Gibco) and single
cell suspension plated into 10 cm dishes (Corning) in 50% advanced
DMEM/F-12 (Gibco), 50% Neurobasal medium (Gibco), 10% Knockout
serum replacement (Gibco) and 2 mM L-glutamine and 0.01% Peni-
cillin-streptomycin and 0.1 mM 2-mercaptoethanol (ADFNK medium).
1 μM retinoid acid (Merck) and 0.5 μM smoothened agonist (Merck)
was added on day four and embryoid bodies were split on day six and
eight. Embryoid bodies were collected and disaggregated on day nine.
Embryoid bodies were collected and settled by gravity, washed with
PBS and incubated with 2 ml of Accumax (Merck) for 10 min at 37 °C.
Cells were filtered through a 40 μm cell strainer (Corning) and plated
on poly-L-ornithine (Merck) and laminin (Gibco) -coated plates in
ADFNK medium plus retinoid acid, smoothened agonist and growth
factors (10 ng/ml GDNF, 10 ng/ml BDNF, 25 ng/ml CNTF and 10 ng/ml
NT-3; PeproTech). Mature motor neurons were ready for analysis after
2 days on day eleven. To examine the effect of oxidative stress, motor
neurons were treated with 0.5 mM sodium arsenite (NaAsO2; Merck) in
growth media for 30 or 60 min. Cultured cells were then washed with
PBS and either fixed with 4% PFA for immunocytochemistry or lysed
with 1% NP-40 buffer for protein extraction and co-immunoprecipita-
tion. Survival was assessed 4 h after 60 min of 0.5 mM NaAsO2 treat-
ment using an MTS Assay (Promega) relative to an untreated sample.
The cultures were kept at 37 °C and 5% CO2 for the duration of the
experiments.
4.2. Human cellular models
HEK293T cells were transfected using Lipofectamine 2000
(Invitrogen) with full-length human TDP-43 with a C-terminal
turboGFP-Tag (TDP-43 Human Tagged ORF Clone [Origene, CAT#:
RG210639]) +/− M337V mutation inserted by site-directed muta-
genesis (210,515, Agilent), TDP-43 empty control vector or N-terminal
truncated TDP-43 ‘tdp43-EGFP construct 5’ (a gift from Zuoshang Xu:
Addgene plasmid #28198; http://n2t.net/addgene:28198;
RRID:Addgene_28,198) (Yang et al., 2010).
All iPSC lines were reprogrammed from skin biopsy fibroblasts in
the James Martin Stem-Cell Facility, University of Oxford, using stan-
dardized protocols as previously described (Dafinca et al., 2016).
Human motor neurons (MNs) were differentiated from iPSCs for
30 days before conditioned media was retrieved for vesicle experi-
ments, as previously described (Maury et al., 2015). Briefly, monolayers
of iPSCs were induced in DMEM/F12/Neurobasal with N2 supplement
(Life Technologies), B27 supplement (Life Technologies), ascorbic acid
(0.5 μM), 2-mercaptoethanol (Life Technologies), 1 μM compound C
(Millipore) and 3 μM Chir99021 (Bio-Techne) for 4 days. After 4 days in
culture, 1 μM retinoic acid (Merck) and 500 nM smoothened agonist
(Bio-Techne) were added to the medium. On day 5, Chir99021 and
compound C were removed from the medium, and the cells were cul-
tured for another 4–5 days. Neural precursors were then dissociated and
plated at a low density for 7 days. The medium was supplemented with
10 ng/ml BDNF (Life Technologies), 10 ng/ml GDNF (Life Technolo-
gies), 10 μM DAPT and laminin (0.5 mg/ml). After 7 days, DAPT was
removed from the medium, and the neurons were allowed to mature for
another 2 weeks before functional experiments. A full description of the
validation of this differentiation protocols has been described elsewhere
(Dafinca et al., 2020).
4.3. Mass spectrometry and bioinformatics
For the study of the TDP-43 interactome, a total of 3 differentiations
of mouse ESC-derived motor neurons harbouring human TDP-43WT/−
or TDP-43M337V/− with or without 0.5 mM NaAsO2 treatment for
60 min were generated. Cells were washed with PBS, incubated with
1% NP-40 buffer with 100 x HALT protease phosphatase inhibitor
(ThermoFisher) for 5 min on ice, cells were scraped and centrifuged for
10 min at 10,000 ×g at 4 °C. 500 μg of protein lysate was used per
immunoprecipitation reaction. YPet-tagged human TDP-43 was co-im-
munoprecipitated using GFP antibody-coated magnetic-agarose beads
for 1 h (Chromotek, Germany). Beads were washed three times with
wash buffer (10 mM Tris/Cl, 150 mM NaCl, 0.5 mM EDTA pH 7.5) and
immunoprecipitated proteins bound to YPet-TDP-43 were directly di-
gested with trypsin/lysC using in-StageTip method and frozen at
−80 °C prior to elution for mass spectrometry following the manufac-
turer's instructions (Preomics, Germany). Interactors of human TDP-43
were identified by high performance liquid-chromatography tandem
mass spectrometry (LC-MS/MS) using an Orbitrap Fusion Lumos mass
spectrometer (ThermoScientific). Raw MS data were analysed using
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Progenesis QI for Proteomics software v3.0 (Nonlinear Dynamics). MS/
MS spectra were searched against the Mus musculus reference proteome
(retrieved 15/11/2016) including the YPet-sequence using Mascot
v2.5.1 (Matrix Science) allowing for a precursor mass tolerance of
10 ppm and a fragment ion tolerance of 0.5 Da. Carbamidomethylation
on cysteines was defined as fixed modification and variable modifica-
tion included deamidation on asparagine and glutamine and oxidation
on methionine.
The peptide false discovery rate (FDR) was set at 1% and all pep-
tides with an ion score higher than 20 were imported into Progenesis
QIP. To further improve confidence in protein identification at least two
peptides were required for protein identification, with 0.1% peptide
FDR and 1% protein FDR. Protein abundance values were normalized to
the median abundance of the 90% of proteins with the lowest variance
across all runs and compared by t-test, with a FDR-adjusted p-value of
≤0.05 for significant differences and fold changes between TDP-43wt
and TDP-43M337V interactors were calculated. For interactors where ion
abundances were missing approximate quantification by peptide spec-
tral count was used. A protein was defined as a putative interactor with
≥2 unique peptide spectra when 0 or 1 in the other interactome or ≥ 1
unique peptide spectral count when completely absent in the other
interactome.
Gene ontology (GO) enrichment analysis was performed using
TopGO (R-studio Version 1.1.383) applying a target-background ap-
proach at the gene level, with specific interactors of the TDP-43WT (> 3
peptide spectral counts) or TDP-43M337V +/− NaAsO2 interactome as
the foreground list. The background list comprised all proteins identi-
fied over all twelve samples combined. Proteins of the interactomes
significantly annotated to a GO term were determined by Fisher's exact
test with a p-value<0.05. The odds ratio (OR) indicates the ratio of
significant identified proteins in the foreground list to the expected
presence of proteins. Calculations were made to identify over-
represented biological processes, cellular components and molecular
functions. The top results are shown with the number of significant
proteins (p < 0.05) identified in each GO term annotated using
ggplot2 version 0.9.0 (R-studio Version 1.1.383, H. Wickham. ggplot2:
Elegant Graphics for Data Analysis. Springer-Verlag New York, 2016). A
visual network of protein-protein interactions was generated by
STRING (consortium 2019) utilized through Cytoscape v3.3.0 selecting
Mus musculus organism and high confidence interactions.
4.4. Immunohistochemistry and microscopy
Cells cultured on glass coverslips were fixed with 4% PFA-PBS for
15 min and blocked with 5% normal donkey serum with 0.1% Triton X-
100 for 1 h at room temperature (RT). The cells were incubated over-
night with primary antibody diluted in 1% donkey serum (mouse or
rabbit anti-Tuj1 (Covance, 1:1000), mouse anti-Islet1 (40.2D6-A,
Developmental Studies Hybridoma Bank, 1:1000), goat anti-ChAT
(ab144P, Millipore, 1:500), rabbit anti-GFP (Invitrogen, 10,474,172,
1:1000), rabbit anti-cleaved-caspase 3 (9661, Cell Signaling, 1:500),
rabbit anti-PABPc protein (ab21060, Abcam, 1:1000). After washing
with 0.1% Triton-X/PBS for 10 min three times the samples were in-
cubated with Alexa Fluor 488 or Alexa Fluor 568 conjugated donkey
anti-rabbit, anti-mouse or anti-goat secondary antibodies (Life
Technologies, 1:1000) for 1 h at RT. After washing with 0.1% Triton-X/
PBS for 10 min twice, nuclei were stained with 4′,6-Diamidino-2-
Phenylindole (DAPI) for 10 min. Coverslips were mounted and fluor-
escence was visualized using a confocal microscope Zeiss LSM. Cells
from six randomly chosen-fields were counted and percentage of total
cells (at least 60 total cells) averaged for each differentiation. Statistical
analysis compared average values from each differentiation (total dif-
ferentiations per experiment n = 3).
4.5. Stress granule analysis
Images for stress granules were acquired with an 63× objective and
10.24 resolution. Images were produced with z-stacks (0.25 μm in-
terval) with a scan area 1.0–1.5 zoom in Zen lite 2012 software (Zeiss)
and z-projected using Fiji version 1.0 of ImageJ. The number of cells
with stress granules were counted and given as percentage of the total
cell count. The number and area of stress granules per motor neuron
were assessed by an automated macro analysis programmed for the
recognition of stress granules of the size from 100nm2 to 1.5μm2 (Fiji
version 1.0 of ImageJ).
4.6. Immunoprecipitation and immunoblotting
For Co-immunoprecipitations cells were lysed with 1% NP-40 buffer
as described above. 1000 - 2000 μg of protein lysate was used per
immunoprecipitation reaction. For RNase treatment.
protein extracts were incubated with either vehicle (10 mM Tris-
HCl, pH 7.5, 15 mM NaCl) or 330 μg of RNAse A (Roche) for 10 min at
37 °C on a shaker. After samples have been cooled on ice followed by
co-immunoprecipitation. YPet-tagged human TDP-43 was co-im-
munoprecipitated using 25 μl of GFP antibody-coated magnetic-agarose
beads per sample (Chromotek). turboGFP-tagged human TDP-43 was
co-immunoprecipitated using 25 μl of turboGFP (tGFP) antibody-coated
magnetic-agarose beads per sample (Chromotek). IP-eluates were di-
rectly suspended in 30 μl 2× LDS sample buffer and 7.5 μl of 4× LDS
buffer was added to 19 μl of the supernatants. All samples were sup-
plemented with 10× reducing agent (Invitrogen) and boiled at 95 °C
for 10 min. Sample were run on a 4–12% gradient precast gel
(Invitrogen) at 135 V for 2.5 h in MOPS running buffer (Invitrogen).
Membranes were blocked in TBS protein free blocking buffer
(ThermoFisher) and incubated overnight with primary antibody, as
follows: rabbit anti-GFP (10,474,172, Invitrogen, 1:1000), rabbit ant-
turboGFP (PA5–22688, Invitrogen, 1:1000) rabbit anti-PABPc
(ab21060, Abcam, 1:1000), rabbit anti-TDP-43 (10782–2-AP,
Proteintech, 1:1000), rabbit anti-Eif4a1 (2490, Cell signaling, 1:1000),
rabbit anti-Tmed9 (SAB2700249, Merck, 1:1000), rabbit anti-Grp78
(ab21685, Abcam, 1:1000), diluted in protein free blocking buffer fol-
lowed by respective secondary antibodies (Novus Biologicals, 1:10000).
ECL (GE Healthcare, RPN2232) signal was visualized using the BioRad
ChemiDoc imaging system. Signal intensity was quantified using the Fiji
version 1.0 of ImageJ. After immunoblotting the immunoreactivity of
the co-immunoprecipitated protein was semi-quantified relative to the
normalized immunoreactivity of the immunoprecipitated bait protein
after stripping the membrane.
4.7. Ultrafiltration liquid chromatography and extracellular vesicle
characterization
Extracellular vesicle (EV) characterizations were performed in EV-
depleted media prepared by ultracentrifugation for respective cell cul-
ture mediums centrifuged at 120,000 ×g for 18 h (Beckman Coulter,
Optima MAX-XP Ultracentrifuge). Motor neuron cultures were plated at
equal density on a 6-well plate. On day eleven motor neuron cultures
were exposed to EV-depleted conditioned media +/− 0.5 mM NaAsO2
for 60 min, the media was then collected and immediately frozen at
−80 °C. Collected media was then defrosted on ice and centrifuged and
following filtration (0.22 μm), samples were filtered using Amicon
Ultra-15,100 kDa molecular weight cut-off (MWCO) centrifugal filters
(Merck Millipore) at 3500 ×g for 8 min, washed with PBS and cen-
trifuged at 3500 ×g for 4 min. Retentate volume was adjusted to 800 μL
with PBS, injected into a 24 ml size exclusion column packed with se-
pharose 4 fastflow (mean particle size 90 μm, exclusion limit 3 × 107)
and eluted with 40 ml PBS at 0.5 ml per minute using an AKTA pure
chromatography system (GE Life Sciences). Two millilitre fractions
were collected from six to 40 ml elution volume. Extracellular size
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distribution and concentration was ascertained using nanoparticle
tracking analysis (NTA) using a NanoSight NS500 (Malvern Ltd) and
NTA 2.3 software. Size distribution was averaged across three 30 s re-
cordings per sample (Thompson et al., 2018). Immunoblotting for po-
sitive markers rabbit anti-Alix (ab186429, Abcam, 1:1000), rabbit anti-
TSG101 (ab125011, Abcam, 1:500) and mouse anti-Flotillin-1 (Novus
Biologicals, 1:1000), as well as negative markers rabbit anti-Tomm-20
(ab56783, Abcam, 1:1000), rabbit anti-Erp44 (SAB1410402, Merck,
1:1000) and mouse anti-Lamin B (X223, Invitrogen, 1:1000) was done
by collecting EV containing fractions 2 and 3 in ultracentrifuge tubes
and centrifuge for 120 000 ×g for 2 h at 4 °C. Supernatant was collected
as negative control and the vesicle pellet washed with PBS and cen-
trifuged 120 000 ×g for 2 h again. The vesicle pellet was then dissolved
in 4xLDS sample buffer.
4.8. Transmission electron microscopy
10 μL of EV solution was applied to freshly glow-discharged carbon-
coated 200 mesh copper grids for 2 min, blotted with filter paper and
stained with 2% uranyl acetate for 10 s, blotted and air dried. Grids
were imaged in a FEI Tecnai 12 transmission electron microscope at
120 kV using a Gatan OneView CMOS camera. Particle size was mea-
sured using ImageJ v1.50i (National Institutes of Health, USA).
4.9. Statistical analysis
Proteomic analysis is detailed above. Data are presented as mean
and standard deviation and unpaired t-test was used to assess sig-
nificant differences (p < 0.05). One-way ANOVA analysis was used to
determine statistical differences between three or more groups. The
exact value of the number of replicates and the statistical test and result
are given in the figure legends. Statistical analysis was carried out using
R-Studio and GraphPad Prism 7 (version7b, 2016).
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